|
INKT Mink Therapeutics Inc 1840229 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,128,201.00 |
| Balance Sheet |
|
Current Assets
|
$9,296,768.00 |
|
Assets
|
$9,615,242.00 |
|
Current Liabilities
|
$7,568,743.00 |
|
Equity
|
$-14,028,296.00 |
|
Shares Out
|
5096658.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,815,409.00 |
|
Investing Cash Flow
|
$-73,561.00 |
| Market Analysis |
Market Cap
|
$59,223,165.96 |
|
Price
|
$12.05 |
|
PB
|
5.23 |
|
EPS
|
-0.62 |
|
FCF
|
$-3,888,970.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:53 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:44 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-0.56 |
|
|
2026-05-15 |
-0.57 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-1.06 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INKT documents filed with the SEC.
INKT Filings
Clear
